MTS Backing Will Support Growth of myNEXUS and Its Unique Care Management Solution
New York and Brentwood, TN, October 24, 2014 — MTS Health Investors, LLC (“MTS”), the New-York based healthcare private equity firm, announced today that funds managed by MTS have completed a majority investment in myNEXUS, Inc. (“myNEXUS” or “the Company”). myNEXUS is a technology-driven, care management service that has a proven track record of reducing hospital readmissions and lowering costs. The Company delivers its program on behalf of leading healthcare payors and in collaboration with a broad array of provider groups and technology affiliates. This investment was made from MTS Health Investors III, L.P. Harpeth Capital advised the Brentwood-based company on the financing. Terms of the transaction were not disclosed.
myNEXUS’s proprietary data and analytics enable an accurate and informed care management process to determine optimal care utilization. Furthermore, overall healthcare costs are reduced by incorporating daily biometric monitoring technology to facilitate more informed and timely intervention for the chronically ill. myNEXUS is positioned to provide these services to many of the leading health care industry stakeholders including insurers, employer groups, accountable care organizations, hospital systems and integrated delivery networks.
The Company’s senior management team will continue to be led by co-founders John W. “Wally” Dant, III and McArthur VanOsdale, who serve as Executive Chairman and CEO, respectively. Mr. Dant and Mr. VanOsdale will hold a significant ownership stake in the company.
MTS partner Oliver T. Moses, said, “We are thrilled to be backing a tremendously seasoned team of executives at myNEXUS. Their collective experience working with leading providers and payors has resulted in a program that provides an advanced approach to coordinating care for individuals in their home environment. This program represents a highly sought-after solution that reduces waste and improves clinical outcomes across pre- and post-acute populations.”
Mr. VanOsdale added, “myNEXUS is excited to partner with MTS Health Investors as we take the company to its next growth phase. In addition to capital, MTS’s experience and deep industry relationships will enable us to execute on our strategy. We look forward to working with them in expanding our platform and broadening our reach with payors, providers and the individuals we serve.”
myNEXUS, based in Brentwood, Tennessee, acts as a link that connects many parts of the healthcare system including individuals, physicians, health providers and insurers. myNEXUS’s care management team focuses on reducing waste by managing care according to proven clinical criteria and business intelligence. For individuals with chronic conditions, the company uses a daily biometric monitoring system which allows them to detect, prevent and intervene at the appropriate times resulting in better outcomes, decreased re-hospitalizations and lower costs. For further information, please visit www.mynexuscare.com.
MTS Health Investors, LLC, located in New York, is a healthcare private equity firm that makes investments in operating companies within the healthcare industry. MTS targets companies that provide cost-effective solutions in the services and low-technology manufacturing sectors of the healthcare industry. Industry sectors in which MTS invests include: providers of outsourced solutions to the healthcare industry; providers of direct medical services to patients in an institutional, ambulatory, or home setting; providers of managed care and other healthcare insurance services; distributors of medical products; and manufacturers of medical devices and supplies. For further information, please visit www.mtshealthinvestors.com.